In line with this, Suzuki and colleagues recently demonstrated that Gls2-deficient mice or GLS2-depleted human cancer cells are significantly resistant to ferroptosis and this can contribute to the onset of liver cancer. This evidence concerns the gene GLS2 and liver cancer.